Asthma
COPD
Pulmonary
COPD: Page 9
Blood tests, sputum analysis could predict COPD risks
Research suggests risk profiles could be assessed by measuring blood eosinophil counts and analyzing sputum.
December 11, 2025
Antibody shows promise in reducing severe COPD
Phase 2a results for anti-ST2 antibody demonstrate safety, tolerability, reduction in annualized rate of exacerbations.
December 11, 2025
New decision-making framework could change COPD care
A consortium of European researchers has developed a classification system for severity of exacerbations.
December 4, 2025
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Testing lung function earlier may help identify COPD risk
Earlier risk assessment could allow for more timely interventions.
December 4, 2025
Machine learning could transform acute risk assessment in COPD
Research suggests a multi-algorithm approach could be used for precise clinical phenotyping.
November 25, 2025
A potential new biomarker for high-risk COPD patients
Systemic immune-inflammation index could be a useful assessment tool for patients with COPD and atrial fibrillation.
November 19, 2025
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Men, women face different challenges with COPD, lung diseases
Survey examines the importance of patient-reported outcomes and personalized care.
November 19, 2025
Inhalation solution could provide alternative for COPD patients
HL231 offered equivalent efficiency as a nebulized alternative to other inhalants.
November 11, 2025
Staged versus simultaneous bilateral lung volume reduction surgery
Staged surgery edges out simultaneous surgery in comparison among patients with severe emphysema.
November 11, 2025
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
Study investigates role of mucus plugs in COPD
Understanding the underlying body of mucus pathology could pave the way to identifying new therapeutic targets.
November 6, 2025
COPD Foundation calls for rural focus on COPD research
Perspective seeks consideration of social, cultural and environmental factors shaping lung health in rural communities.
November 6, 2025
Emphysema treatment meets key endpoints in phase 2 study
Efdoralprin alfa is aimed at treating adults with alpha-1 antitrypsin deficiency emphysema.
October 30, 2025
Previous Page
Page 9 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial